Table I.
Assays | Treatment | ||||||||
---|---|---|---|---|---|---|---|---|---|
Control | DMBA | DMBA + TQL | DMBA + TQM | DMBA + TQH | DMBA + BCSL | DMBA + BCSM | DMBA + BCSH | DMBA + FU | |
MDA | 7.1 ±0.2b | 15.3 ±0.32a | 13.4 ±0.22a | 12.7 ±0.34a | 9.2 ±0.21b | 15.1 ±0.12a | 13.8 ±0.14a | 10.1 ±0.11b | 8.9 ±0.32b |
LDH | 162.2 ±4.1d | 983.6 ± 12.1a | 813.6 ± 10.1a | 616.7 ± 11.8b | 399.1 ± 10.4c | 914.3 ± 11.1a | 766.1 ± 10.1b | 623.2 ± 14.2b | 345.6 ± 11.8c |
ALP | 141.2 ± 2.6c | 365.5 ± 14.4a | 305.3 ± 11.2a | 218.1 ± 9.7b | 179.2 ± 8.1c | 325.4 ± 12.6a | 276.6 ± 8.6ab | 219.6 ± 10.1b | 168.6 ± 9.2c |
AST | 24.5 ±0.67c | 64.4 ±5.7a | 55.5 ±4.8a | 39.8 ±3.8ab | 29.4 ±3.2b | 58.2 ±3.7a | 46.3 ±4.4a | 38.9 ±4.6a | 30.7 ±1.1b |
ALT | 33.4 ±0.1b | 69.7 ±3.7a | 57.9 ±4.6a | 44.8 ±2.9ab | 39.1 ±1.7b | 62.8 ±3.6a | 51.2 ±1.9a | 42.1 ±2.3ab | 39.4 ±2.2b |
DMBA – 7,12-dimethylbenz[a]anthracene, TQ – thymoquinone, BCS – black cumin seed, FU – 5-fluorouracil, L – low dose, M – medium dose, H – high dose. Means showing different lettering in a row differed significantly at p < 0.05.
p < 0.05 compared to control group
p < 0.05 compared to DMBA group
p < 0.05 compared to DMBA + TQ and BCS groups, respectively. Data were analyzed by ANOVA followed by Scheffe test